Clinicopathologic features of metachronous or synchronous gastric cancer patients with three or more primary sites.

The survival differences between the synchronous and metachronous GC-MPC groups were significant in male (p=0.002), stage I/II (p=0.011) and well differentiated histology (p=0.01) groups, while the difference in female (p=0.629), stage III/IV (p=0.502) and poorly differentiated histology (p=0.154) groups did not reach statistical significance ( Table 3 ).

also in 111,027 other papers